Pediatrix Medical Group, Inc. (NYSE:MD) Short Interest Down 35.6% in March

Pediatrix Medical Group, Inc. (NYSE:MD) was the target of a large drop in short interest in March. As of March 31st, there was short interest totalling 1,860,000 shares, a drop of 35.6% from the March 15th total of 2,890,000 shares. Based on an average daily volume of 660,000 shares, the short-interest ratio is currently 2.8 days. Approximately 2.2% of the shares of the stock are short sold.

Wall Street Analysts Forecast Growth

Several equities analysts have weighed in on the company. Truist Financial dropped their price target on Pediatrix Medical Group from $18.00 to $16.00 and set a “hold” rating for the company in a research report on Friday, April 11th. UBS Group boosted their target price on shares of Pediatrix Medical Group from $16.50 to $18.50 and gave the company a “neutral” rating in a report on Friday, February 21st. Finally, StockNews.com upgraded Pediatrix Medical Group from a “hold” rating to a “buy” rating in a report on Wednesday, January 22nd. Four analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $16.75.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the stock. State Street Corp raised its stake in shares of Pediatrix Medical Group by 1.4% during the third quarter. State Street Corp now owns 3,540,791 shares of the company’s stock valued at $41,038,000 after purchasing an additional 50,597 shares in the last quarter. Nordea Investment Management AB grew its holdings in Pediatrix Medical Group by 51.6% during the fourth quarter. Nordea Investment Management AB now owns 263,633 shares of the company’s stock worth $3,504,000 after acquiring an additional 89,739 shares during the period. Barclays PLC lifted its holdings in Pediatrix Medical Group by 302.9% in the 3rd quarter. Barclays PLC now owns 142,087 shares of the company’s stock valued at $1,646,000 after acquiring an additional 106,817 shares during the last quarter. Franklin Resources Inc. bought a new stake in Pediatrix Medical Group during the third quarter worth approximately $598,000. Finally, Principal Financial Group Inc. increased its holdings in shares of Pediatrix Medical Group by 14.1% in the third quarter. Principal Financial Group Inc. now owns 513,618 shares of the company’s stock valued at $5,953,000 after buying an additional 63,581 shares in the last quarter. 97.71% of the stock is currently owned by institutional investors.

Pediatrix Medical Group Stock Down 2.2 %

Shares of NYSE:MD traded down $0.29 during midday trading on Thursday, reaching $12.85. The company had a trading volume of 483,614 shares, compared to its average volume of 838,504. Pediatrix Medical Group has a one year low of $6.62 and a one year high of $17.67. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.60 and a quick ratio of 1.42. The stock has a market capitalization of $1.10 billion, a P/E ratio of -10.71, a PEG ratio of 1.74 and a beta of 1.32. The stock’s fifty day moving average price is $14.30 and its 200-day moving average price is $13.94.

Pediatrix Medical Group (NYSE:MD) last released its quarterly earnings data on Thursday, February 20th. The company reported $0.49 EPS for the quarter, topping analysts’ consensus estimates of $0.37 by $0.12. Pediatrix Medical Group had a negative net margin of 4.92% and a positive return on equity of 15.47%. The firm had revenue of $502.36 million during the quarter, compared to the consensus estimate of $486.22 million. Equities research analysts expect that Pediatrix Medical Group will post 1.38 earnings per share for the current fiscal year.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.